A D Cooper

3.0k total citations
46 papers, 2.6k citations indexed

About

A D Cooper is a scholar working on Surgery, Molecular Biology and Epidemiology. According to data from OpenAlex, A D Cooper has authored 46 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Surgery, 19 papers in Molecular Biology and 13 papers in Epidemiology. Recurrent topics in A D Cooper's work include Cholesterol and Lipid Metabolism (14 papers), Cancer, Lipids, and Metabolism (13 papers) and Liver Disease Diagnosis and Treatment (7 papers). A D Cooper is often cited by papers focused on Cholesterol and Lipid Metabolism (14 papers), Cancer, Lipids, and Metabolism (13 papers) and Liver Disease Diagnosis and Treatment (7 papers). A D Cooper collaborates with scholars based in United States, United Kingdom and Italy. A D Cooper's co-authors include Sandra K. Erickson, Jeff L. Ellsworth, Loren G. Fong, Wendy Y. Craig, Sara Choi, Fredric B. Kraemer, Penny M. Kris‐Etherton, Peter Y. Yu, M. Carrella and R. Gordon Gould and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

A D Cooper

45 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A D Cooper United States 32 1.3k 921 776 488 433 46 2.6k
Y S Chao United States 16 986 0.8× 748 0.8× 831 1.1× 530 1.1× 284 0.7× 19 2.3k
Peter J. Dolphin Canada 30 1.1k 0.9× 974 1.1× 1.0k 1.3× 408 0.8× 327 0.8× 79 2.7k
Richard W. St. Clair United States 32 1.4k 1.2× 821 0.9× 645 0.8× 401 0.8× 399 0.9× 103 3.0k
Gertrud Wolfbauer United States 26 999 0.8× 924 1.0× 637 0.8× 400 0.8× 414 1.0× 43 2.5k
Mitsuyo Okazaki Japan 32 1.3k 1.0× 1.1k 1.1× 1.2k 1.6× 594 1.2× 520 1.2× 92 3.2k
R C Pittman United States 25 2.1k 1.7× 1.3k 1.4× 1.1k 1.5× 781 1.6× 399 0.9× 32 3.8k
Brian R. Krause United States 33 2.0k 1.6× 1.3k 1.4× 771 1.0× 619 1.3× 231 0.5× 94 3.1k
Donald B. Zilversmit United States 29 1.0k 0.8× 1.5k 1.6× 752 1.0× 385 0.8× 266 0.6× 51 2.9k
Elaine L. Gong United States 21 1.2k 0.9× 772 0.8× 1.1k 1.4× 464 1.0× 215 0.5× 34 2.1k
Allen D. Cooper United States 26 967 0.8× 593 0.6× 783 1.0× 298 0.6× 317 0.7× 63 2.1k

Countries citing papers authored by A D Cooper

Since Specialization
Citations

This map shows the geographic impact of A D Cooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A D Cooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A D Cooper more than expected).

Fields of papers citing papers by A D Cooper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A D Cooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A D Cooper. The network helps show where A D Cooper may publish in the future.

Co-authorship network of co-authors of A D Cooper

This figure shows the co-authorship network connecting the top 25 collaborators of A D Cooper. A scholar is included among the top collaborators of A D Cooper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A D Cooper. A D Cooper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Harris, Adrienne N., et al.. (2025). Antidiuretic hormone concentrations in dogs with heart disease and relationship to serum chloride. Journal of Veterinary Cardiology. 59. 15–23.
2.
3.
Ho, Edith Y., Nghiem B. Ha, Aijaz Ahmed, et al.. (2011). Prospective study of risk factors for hepatitis C virus acquisition by Caucasian, Hispanic, and Asian American patients. Journal of Viral Hepatitis. 19(2). e105–11. 17 indexed citations
4.
Mustad, Vikkie A., Terry D. Etherton, A D Cooper, et al.. (1997). Reducing saturated fat intake is associated with increased levels of LDL receptors on mononuclear cells in healthy men and women. Journal of Lipid Research. 38(3). 459–468. 76 indexed citations
5.
Cooper, A D. (1997). Hepatic uptake of chylomicron remnants. Journal of Lipid Research. 38(11). 2173–2192. 360 indexed citations
6.
Faria, Eliana Cotta de, Loren G. Fong, M C Komaromy, & A D Cooper. (1996). Relative roles of the LDL receptor, the LDL receptor-like protein, and hepatic lipase in chylomicron remnant removal by the liver.. Journal of Lipid Research. 37(1). 197–209. 67 indexed citations
7.
Pak, Youngmi Kim, et al.. (1996). Activation of LDL receptor gene expression in HepG2 cells by hepatocyte growth factor. Journal of Lipid Research. 37(5). 985–998. 44 indexed citations
8.
Fong, Loren G., et al.. (1995). Location and regulation of low-density lipoprotein receptors in intestinal epithelium. American Journal of Physiology-Gastrointestinal and Liver Physiology. 269(1). G60–G72. 14 indexed citations
9.
Bocchetta, Maurizio, G. Bruscalupi, Flavia Castellano, et al.. (1993). Early induction of LDL receptor gene during rat liver regeneration. Journal of Cellular Physiology. 156(3). 601–609. 20 indexed citations
10.
Jaruratanasirikul, Sutep, A D Cooper, & Terrence F. Blaschke. (1992). Inhibition of debrisoquin clearance in perfused rat livers and inhibition of dextromethorphan metabolism in human liver microsomes by 4-hydroxydebrisoquin or other metabolites of debrisoquin.. Drug Metabolism and Disposition. 20(3). 379–382. 5 indexed citations
11.
Ellsworth, Jeff L., Chitra Chandrasekaran, & A D Cooper. (1991). Evidence for sterol-independent regulation of low-density lipoprotein receptor activity in Hep-G2 cells. Biochemical Journal. 279(1). 175–187. 25 indexed citations
12.
Cooper, A D, et al.. (1991). Inhibition of lipopolysaccharide-induced interleukin-1 beta mRNA expression in mouse macrophages by oxidized low density lipoprotein.. Journal of Lipid Research. 32(12). 1899–1910. 76 indexed citations
13.
Choi, Sara, et al.. (1991). Use of an anti-low density lipoprotein receptor antibody to quantify the role of the LDL receptor in the removal of chylomicron remnants in the mouse in vivo.. Journal of Clinical Investigation. 88(4). 1173–1181. 81 indexed citations
14.
Fong, Loren G., Elizabeth A. Bonney, Jon C. Kosek, & A D Cooper. (1989). Immunohistochemical localization of low density lipoprotein receptors in adrenal gland, liver, and intestine.. Journal of Clinical Investigation. 84(3). 847–856. 46 indexed citations
15.
Craig, Wendy Y., et al.. (1988). Regulation of apoprotein synthesis and secretion in the human hepatoma Hep G2. The effect of exogenous lipoprotein.. Journal of Biological Chemistry. 263(27). 13880–13890. 82 indexed citations
16.
Craig, Wendy Y. & A D Cooper. (1988). Effects of chylomicron remnants and beta-VLDL on the class and composition of newly secreted lipoproteins by HepG2 cells.. Journal of Lipid Research. 29(3). 299–308. 32 indexed citations
18.
Kris‐Etherton, Penny M. & A D Cooper. (1980). Studies on the etiology of the hyperlipemia in rats fed an atherogenic diet. Journal of Lipid Research. 21(4). 435–442. 72 indexed citations
19.
Gebhard, R L & A D Cooper. (1978). Regulation of cholesterol synthesis in cultured canine intestinal mucosa.. Journal of Biological Chemistry. 253(8). 2790–2796. 43 indexed citations
20.
Erickson, Sandra K., A D Cooper, S. Matsui, & R. Gordon Gould. (1977). 7-Ketocholesterol. Its effects on hepatic cholesterogenesis and its hepatic metabolism in vivo and in vitro.. Journal of Biological Chemistry. 252(15). 5186–5193. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026